|
Market Closed -
Nasdaq
23:00:00 09/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 5.670 USD | +2.53% |
|
+5.39% | -44.84% |
| Market Cap | 204M 183M 170M 154M 292M 19.79B 293M 2.04B 801M 10.09B 768M 751M 32.37B | P/E 2026 * |
-1.41x | P/E 2027 * | -1.57x |
|---|---|---|---|---|---|
| Enterprise Value | 174M 156M 145M 132M 249M 16.87B 250M 1.74B 683M 8.6B 655M 640M 27.6B | EV / Sales 2026 * |
14.3x | EV / Sales 2027 * | -3.26x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
CBOE
| TRDA | Real-time |
Last Transcript: Entrada Therapeutics, Inc.
| 21/12/22 | Nipte winst op Wall Street | |
| 20/12/22 | Wall Street licht hoger | |
| 20/12/22 | Wall Street richting rode opening |
| 1 day | +2.53% | ||
| 1 week | +5.39% | ||
| Current month | -10.71% | ||
| 1 month | -20.25% | ||
| 3 months | -23.38% | ||
| 6 months | -59.64% | ||
| Current year | -44.84% |
| 1 week | 5.15 |  | 5.75 |
| 1 month | 5.15 | | 7.07 |
| Current year | 5.15 | | 16.45 |
| 1 year | 5.15 | | 16.45 |
| 3 years | 4.93 | | 21.79 |
| 5 years | 4.93 | | 36.85 |
| 10 years | 4.93 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 01/08/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 01/11/2020 |
Nathan Dowden
PSD | President | 56 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 01/08/2017 |
Kush Parmar
CHM | Chairman | 45 | 01/12/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 01/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/26 A | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 9/9/26 A | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 9/3/26 A | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.53% | +5.39% | -16.49% | -60.21% | 204M | |
| -2.59% | -5.70% | +39.83% | +82.45% | 70.61B | |
| +3.23% | -10.67% | +4.87% | +55.97% | 51.01B | |
| +1.56% | +1.17% | +5.15% | +33.38% | 48.1B | |
| +0.39% | +0.65% | +28.02% | +30.24% | 42.78B | |
| +0.87% | -8.17% | +298.53% | +645.03% | 40.67B | |
| +1.24% | -1.01% | +5.56% | +105.14% | 40.3B | |
| -2.13% | -1.64% | +7.51% | +50.31% | 30.59B | |
| -0.46% | -1.28% | +31.47% | +19.93% | 28.16B | |
| +5.32% | +0.06% | -7.20% | -11.30% | 24.36B | |
| Average | +1.00% | -1.85% | +39.72% | +95.10% | 37.68B | |
| Weighted average by Cap. | +0.56% | -2.94% | +47.27% | +116.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.17M 10.87M 10.11M 9.19M 17.36M 1.18B 17.43M 122M 47.66M 600M 45.69M 44.69M 1.93B | 22.86M 20.42M 18.99M 17.27M 32.62M 2.21B 32.76M 229M 89.56M 1.13B 85.84M 83.97M 3.62B |
| Net income | -174M -156M -145M -132M -249M -16.87B -250M -1.74B -683M -8.6B -655M -640M -27.61B | -184M -165M -153M -139M -263M -17.85B -264M -1.84B -723M -9.1B -693M -677M -29.2B |
| Net Debt | -30.12M -26.9M -25.03M -22.76M -42.98M -2.92B -43.17M -301M -118M -1.49B -113M -111M -4.77B | -279M -249M -232M -211M -398M -27.01B -400M -2.79B -1.09B -13.77B -1.05B -1.03B -44.19B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | $5.670 | +2.53% | 209,364 |
| 08/10/26 | $5.530 | -1.43% | 361,507 |
| 07/10/26 | $5.610 | +3.51% | 297,512 |
| 06/10/26 | $5.420 | -1.09% | 315,919 |
| 05/10/26 | $5.480 | +1.86% | 463,808 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
